Cerebrolysin 60mg

Cerebrolysin 60mg is a complex, biologically active preparation produced through standardized enzymatic breakdown of purified porcine brain proteins. Unlike single-molecule synthetic peptides, Cerebrolysin contains a heterogeneous mixture of neurotrophic factors and active peptide fragments, including Brain-Derived Neurotrophic Factor (BDNF)-like peptides, Glial Cell Line-Derived Neurotrophic Factor (GDNF)-like peptides, and Nerve Growth Factor (NGF)-like peptides. The 60mg formulation provides a concentrated dose suitable for dilution in cell culture media or buffer systems for advanced neuroscience research applications.

In laboratory settings, Cerebrolysin is primarily utilized to investigate mechanisms of neuroprotection against excitotoxicity, oxidative stress, and amyloid-beta toxicity in primary neuronal cultures and established cell lines. Researchers employ this preparation to study the modulation of synaptic density, dendritic arborization, and the regulation of calcium homeostasis via the PI3K/Akt and MAPK/ERK signaling cascades. Of particular interest is its application in models of ischemic stroke and traumatic brain injury, where the peptide mixture demonstrates pleiotropic effects on reducing neuroinflammation and promoting neurogenesis. This product is provided as a sterile liquid solution in amber ampoules to preserve peptide integrity. It is intended strictly for laboratory research use only and is not approved for human therapeutic administration. Store refrigerated at 2-8°C and protect from light.